SLC3A2 and cancer: Those reviews reported associations between high LAT1 expression and poor overall, cancer-specific, disease-free and progression-free survival, as well as clinicopathological features such as stage, tumor size, lymphatic and vascular invasion, tumor differentiation, Ki-67, 4F2hc, CD34, p53 and ASCT2 [133,134].